This concerns a single-center prospective interventional cohort study. Laboratory-confirmed COVID-19 patients will be asked to donate blood at at least two different timepoints. This will allow us to investigate T and B cell evolutions during the course of infection and recovery. The expected duration of the study is four months or the total duration of the SARS-CoV-2 circulation in Belgium (whichever is shortest).
Inclusion Criteria:
- laboratory confirmed COVID-19 acute infection
- be older than 18 years of age
- be hospitalized at the UZA
- willing and able to provide written informed consent by the participant or its legal
representative (for instance in case of medical incapacitation)
Exclusion Criteria:
- younger than 18 years old
- Ambulatory patients
Universitairy hospital of Antwerp
Antwerp, Belgium
Investigator: Koen Vercauteren
Contact: +32 247 63 32
kvercauteren@itg.be
Koen Vercauteren
+32 3 247 63 32
kvercauteren@itg.be